The Effect of Age on Improvement in Health‐Related Quality of Life After Percutaneous Coronary Intervention
Clinical Cardiology · 2026
DOI: 10.1002/clc.70260 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Clinical Cardiology, 2026. Verfasst von Laura Lappalainen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Kuopio University Hospital, Kuopio, Finland. Hauptthemen laut MEDLINE: Coronary Artery Disease, Percutaneous Coronary Intervention, Quality of Life. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Research Fund of Kuopio University Hospital, Finland, and the Research Council of Finland, Research Foundation of Kuopio University Hospital, Northern-Savo Cultural Foundation.
Abstract (Originalsprache)
Introduction
Percutaneous coronary intervention (PCI) is the first‐line therapy in patients scheduled for coronary revascularization, aiming to relieve symptoms of coronary artery disease (CAD) and improve health‐related quality of life (HRQoL) and prognosis. Particularly, in older adults, symptom alleviation and HRQoL are emphasized. However, it is not known whether older patients benefit from PCI equally to their younger peers. We used disease‐specific and generic instruments to evaluate the improvement in HRQoL after PCI, comparing changes in three age groups.
Methods
Altogether 300 patients undergoing PCI were divided into three age groups: ≥ 75 years ( n = 89), 66–74 years ( n = 117), and ≤ 65 years ( n = 94). HRQoL was measured using the disease‐specific Seattle Angina Questionnaire (SAQ‐7) and the generic 15D instrument at baseline, one, and 12 months.
Results
Statistically and clinically significant improvements in the SAQ‐7 and 15D scores were observed after one‐ and 12‐month follow‐up in all age groups. There were no differences in the 12‐month improvements in the SAQ‐7 and 15D scores between the groups. The 15D score started to decline after 1 month, particularly in the oldest group. The decline was associated with age‐related rather than CAD‐related 15D dimensions.
Conclusions
Our findings on comparable improvement in disease‐specific and generic HRQoL after PCI in older and younger patients are encouraging, particularly considering that the aims of PCI in older adults are predominantly symptom alleviation and improvement of daily activities. In addition, to overcome age‐related changes in HRQoL, a disease‐specific instrument should be incorporated in the evaluation of PCI on HRQoL. Clinical trial registration 5101114.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kuopio University Hospital, Kuopio, Finland.
- University of Eastern Finland, Kuopio, Finland.
- University of Helsinki, Helsinki, Finland and Kuopio University Hospital, Kuopio, Finland.
- University of Helsinki, Helsinki, Finland.
- Kuopio University Hospital, Kuopio, Finland and University of Eastern Finland, Kuopio, Finland.
ORCID-Profile: Laura Lappalainen, Anna-Maija Tolppanen
Förderung
- State Research Fund of Kuopio University Hospital, Finland, and the Research Council of Finland
- Research Foundation of Kuopio University Hospital
- Northern-Savo Cultural Foundation
Zitieren
APA
Lappalainen, L., Lavikainen, P., Roine, R. P., Sintonen, H., Martikainen, J., Tolppanen, A. M., & Hartikainen, J. (2026). The Effect of Age on Improvement in Health‐Related Quality of Life After Percutaneous Coronary Intervention. Clinical Cardiology. https://doi.org/10.1002/clc.70260
Vancouver
Lappalainen L, Lavikainen P, Roine RP, Sintonen H, Martikainen J, Tolppanen AM, et al. The Effect of Age on Improvement in Health‐Related Quality of Life After Percutaneous Coronary Intervention. Clinical Cardiology. 2026. doi:10.1002/clc.70260
BibTeX
@article{Lappalainen2026,
author = {Lappalainen, Laura and Lavikainen, Piia and Roine, Risto P and Sintonen, Harri and Martikainen, Janne and Tolppanen, Anna-Maija and Hartikainen, Juha},
title = {The Effect of Age on Improvement in Health‐Related Quality of Life After Percutaneous Coronary Intervention},
journal = {Clinical Cardiology},
year = {2026},
doi = {10.1002/clc.70260}
}
EUVIMED